SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present 11 abstracts, including one late-breaking abstract at the upcoming ...
The purpose of this letter is to raise the question of corporate personhood and the concomitant responsibility that necessarily attaches to that status, with special reference to local and ...